Cargando…

Clinical presentations and outcomes of patients with Ebola virus disease in Freetown, Sierra Leone

BACKGROUND: Clinical and laboratory data were collected and analysed from patients with Ebola virus disease (EVD) in Jui Government Hospital in Freetown, Sierra Leone, where patients with EVD were received and/or treated from October 1, 2014 to March 21, 2015 during the West Africa EVD outbreak. MET...

Descripción completa

Detalles Bibliográficos
Autores principales: Ji, Ying-Jie, Duan, Xue-Zhang, Gao, Xu-Dong, Li, Lei, Li, Chen, Ji, Dong, Li, Wen-Gang, Wang, Li-Fu, Meng, Yu-Hua, Yang, Xiao, Ling, Bin-Fang, Song, Xue-Ai, Gu, Mei-Lei, Jiang, Tao, Koroma, She-Ku M., Bangalie, James, Duan, Hui-Juan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094140/
https://www.ncbi.nlm.nih.gov/pubmed/27806732
http://dx.doi.org/10.1186/s40249-016-0195-9
_version_ 1782465070083604480
author Ji, Ying-Jie
Duan, Xue-Zhang
Gao, Xu-Dong
Li, Lei
Li, Chen
Ji, Dong
Li, Wen-Gang
Wang, Li-Fu
Meng, Yu-Hua
Yang, Xiao
Ling, Bin-Fang
Song, Xue-Ai
Gu, Mei-Lei
Jiang, Tao
Koroma, She-Ku M.
Bangalie, James
Duan, Hui-Juan
author_facet Ji, Ying-Jie
Duan, Xue-Zhang
Gao, Xu-Dong
Li, Lei
Li, Chen
Ji, Dong
Li, Wen-Gang
Wang, Li-Fu
Meng, Yu-Hua
Yang, Xiao
Ling, Bin-Fang
Song, Xue-Ai
Gu, Mei-Lei
Jiang, Tao
Koroma, She-Ku M.
Bangalie, James
Duan, Hui-Juan
author_sort Ji, Ying-Jie
collection PubMed
description BACKGROUND: Clinical and laboratory data were collected and analysed from patients with Ebola virus disease (EVD) in Jui Government Hospital in Freetown, Sierra Leone, where patients with EVD were received and/or treated from October 1, 2014 to March 21, 2015 during the West Africa EVD outbreak. METHODS: The study admitted 285 patients with confirmed EVD and followed them up till the endpoint (recovery or death). EVD was confirmed by quantitative RT-PCR assays detecting blood Ebola virus (EBOV). RESULTS: Among the 285 lab-confirmed EVD cases in Jui Government Hospital, 146 recovered and 139 died, with an overall survival rate of 51.23 %. Patients under the age of 6 years had a lower survival rate (37.50 %). Most non-survivors (79.86 %) died within 7 days after admission and the mean hospitalization time for non-survivors was 5.56 ± 6.11 days. More than half survivors (63.69 %) turned blood EBOV negative within 3 weeks after admission and the mean hospitalization time for survivors was 20.38 ± 7.58 days. High blood viral load (≥10(6) copies/ml) was found to be predictive of the non-survival outcome as indicated by the Receiver Operating Characteristic (ROC) curve analysis. The probability of patients’ survival was less than 15 % when blood viral load was greater than 10(6) copies/ml. Multivariate analyses showed that blood viral load (P = 0.005), confusion (P = 0.010), abdominal pain (P = 0.003), conjunctivitis (P = 0.035), and vomiting (P = 0.004) were factors independently associated with the outcomes of EVD patients. CONCLUSIONS: Most death occurred within 1 week after admission, and patients at the age of 6 or younger had a lower survival rate. Most surviving patients turned blood EBOV negative within 1–4 weeks after admission. Factors such as high blood viral load, confusion, abdominal pain, vomiting and conjunctivitis were associated with poor prognosis for EVD patients. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s40249-016-0195-9) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5094140
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-50941402016-11-07 Clinical presentations and outcomes of patients with Ebola virus disease in Freetown, Sierra Leone Ji, Ying-Jie Duan, Xue-Zhang Gao, Xu-Dong Li, Lei Li, Chen Ji, Dong Li, Wen-Gang Wang, Li-Fu Meng, Yu-Hua Yang, Xiao Ling, Bin-Fang Song, Xue-Ai Gu, Mei-Lei Jiang, Tao Koroma, She-Ku M. Bangalie, James Duan, Hui-Juan Infect Dis Poverty Research Article BACKGROUND: Clinical and laboratory data were collected and analysed from patients with Ebola virus disease (EVD) in Jui Government Hospital in Freetown, Sierra Leone, where patients with EVD were received and/or treated from October 1, 2014 to March 21, 2015 during the West Africa EVD outbreak. METHODS: The study admitted 285 patients with confirmed EVD and followed them up till the endpoint (recovery or death). EVD was confirmed by quantitative RT-PCR assays detecting blood Ebola virus (EBOV). RESULTS: Among the 285 lab-confirmed EVD cases in Jui Government Hospital, 146 recovered and 139 died, with an overall survival rate of 51.23 %. Patients under the age of 6 years had a lower survival rate (37.50 %). Most non-survivors (79.86 %) died within 7 days after admission and the mean hospitalization time for non-survivors was 5.56 ± 6.11 days. More than half survivors (63.69 %) turned blood EBOV negative within 3 weeks after admission and the mean hospitalization time for survivors was 20.38 ± 7.58 days. High blood viral load (≥10(6) copies/ml) was found to be predictive of the non-survival outcome as indicated by the Receiver Operating Characteristic (ROC) curve analysis. The probability of patients’ survival was less than 15 % when blood viral load was greater than 10(6) copies/ml. Multivariate analyses showed that blood viral load (P = 0.005), confusion (P = 0.010), abdominal pain (P = 0.003), conjunctivitis (P = 0.035), and vomiting (P = 0.004) were factors independently associated with the outcomes of EVD patients. CONCLUSIONS: Most death occurred within 1 week after admission, and patients at the age of 6 or younger had a lower survival rate. Most surviving patients turned blood EBOV negative within 1–4 weeks after admission. Factors such as high blood viral load, confusion, abdominal pain, vomiting and conjunctivitis were associated with poor prognosis for EVD patients. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s40249-016-0195-9) contains supplementary material, which is available to authorized users. BioMed Central 2016-11-03 /pmc/articles/PMC5094140/ /pubmed/27806732 http://dx.doi.org/10.1186/s40249-016-0195-9 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Ji, Ying-Jie
Duan, Xue-Zhang
Gao, Xu-Dong
Li, Lei
Li, Chen
Ji, Dong
Li, Wen-Gang
Wang, Li-Fu
Meng, Yu-Hua
Yang, Xiao
Ling, Bin-Fang
Song, Xue-Ai
Gu, Mei-Lei
Jiang, Tao
Koroma, She-Ku M.
Bangalie, James
Duan, Hui-Juan
Clinical presentations and outcomes of patients with Ebola virus disease in Freetown, Sierra Leone
title Clinical presentations and outcomes of patients with Ebola virus disease in Freetown, Sierra Leone
title_full Clinical presentations and outcomes of patients with Ebola virus disease in Freetown, Sierra Leone
title_fullStr Clinical presentations and outcomes of patients with Ebola virus disease in Freetown, Sierra Leone
title_full_unstemmed Clinical presentations and outcomes of patients with Ebola virus disease in Freetown, Sierra Leone
title_short Clinical presentations and outcomes of patients with Ebola virus disease in Freetown, Sierra Leone
title_sort clinical presentations and outcomes of patients with ebola virus disease in freetown, sierra leone
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094140/
https://www.ncbi.nlm.nih.gov/pubmed/27806732
http://dx.doi.org/10.1186/s40249-016-0195-9
work_keys_str_mv AT jiyingjie clinicalpresentationsandoutcomesofpatientswithebolavirusdiseaseinfreetownsierraleone
AT duanxuezhang clinicalpresentationsandoutcomesofpatientswithebolavirusdiseaseinfreetownsierraleone
AT gaoxudong clinicalpresentationsandoutcomesofpatientswithebolavirusdiseaseinfreetownsierraleone
AT lilei clinicalpresentationsandoutcomesofpatientswithebolavirusdiseaseinfreetownsierraleone
AT lichen clinicalpresentationsandoutcomesofpatientswithebolavirusdiseaseinfreetownsierraleone
AT jidong clinicalpresentationsandoutcomesofpatientswithebolavirusdiseaseinfreetownsierraleone
AT liwengang clinicalpresentationsandoutcomesofpatientswithebolavirusdiseaseinfreetownsierraleone
AT wanglifu clinicalpresentationsandoutcomesofpatientswithebolavirusdiseaseinfreetownsierraleone
AT mengyuhua clinicalpresentationsandoutcomesofpatientswithebolavirusdiseaseinfreetownsierraleone
AT yangxiao clinicalpresentationsandoutcomesofpatientswithebolavirusdiseaseinfreetownsierraleone
AT lingbinfang clinicalpresentationsandoutcomesofpatientswithebolavirusdiseaseinfreetownsierraleone
AT songxueai clinicalpresentationsandoutcomesofpatientswithebolavirusdiseaseinfreetownsierraleone
AT gumeilei clinicalpresentationsandoutcomesofpatientswithebolavirusdiseaseinfreetownsierraleone
AT jiangtao clinicalpresentationsandoutcomesofpatientswithebolavirusdiseaseinfreetownsierraleone
AT koromashekum clinicalpresentationsandoutcomesofpatientswithebolavirusdiseaseinfreetownsierraleone
AT bangaliejames clinicalpresentationsandoutcomesofpatientswithebolavirusdiseaseinfreetownsierraleone
AT duanhuijuan clinicalpresentationsandoutcomesofpatientswithebolavirusdiseaseinfreetownsierraleone